Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07333898 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Measurements of Motor and Voice Functions in FTD

StatusNot Yet Recruiting
PhaseNot specified
SponsorBioSensics
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Feb 1, 2026 to Aug 1, 2026
    • Secondary endpoints: 5 to 4
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
8 trials monitored
See 1 trial at risk
1,978 trials monitored
See 106 trials at risk
The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with FTLD syndromes. Researchers at BioSensics and Johns Hopkins School of Medicine will use wearable sensors, computerized speech, psychomotor, and cognitive assessments to create outcome measures and digital biomarkers for FTLD syndromes. Researchers will deploy this digital health solution to monitor 20 patients with FTLD syndromes for 12 months with study visits every 3 months.
Trial Details
NCT Number NCT07333898
Lead Sponsor BioSensics
Collaborators: Johns Hopkins University
Conditions
(from sponsor)
Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration
Related terms Corticobasal Degeneration, Frontotemporal Dementia, Frontotemporal Lobar Degeneration
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov